In Today's Issue
- Two Rochester Biologists Win Glenn Awards
- Rochester Panel Members Weigh In on Avandia
- Some Students Pull Double Duty
- 'Kids Helping Kids' This Sunday
News and Announcements
Two Rochester Biologists Win Glenn Awards
Associate professors Vera Gorbunova and Heinrich Jasper have won Glenn Awards for Research in Biological Mechanisms of Aging. The $60,000 awards given by the Glenn Foundation for Medical Research are unsolicited, meaning that the researchers who win them do not apply directly, but are recommended by colleagues in their fields.
Rochester Panel Members Weigh In on Avandia
Arthur Moss, director of the Heart Research Follow-up Program, and David Oakes, a professor of biostatistics, participated on the Food and Drug Administration's special scientific advisory panel last week on the drug Avandia. They recommended that Avandia remain on the market as an option for physicians treating patients with Type 2 diabetes.
Some Students Pull Double Duty
As more Rochester students expand their studies to include a second major or degree, a few members of the Class of 2010 talk about why they went that extra step.
'Kids Helping Kids' This Sunday
"Kids Helping Kids," an event featuring a variety of activities for kids and families, will be held from 11 a.m. to 5 p.m. in the parking lot of SouthTown Plaza in Henrietta. Proceeds from the event will benefit Golisano Children's Hospital.
July 22, 2010
Today's Event Highlight
'Images from the Windows of Time'
Mostly Sunny, High 83°
Showers, High 83°
3:30 p.m. Auditorium K-307 (3-6408). Medical Center. Read more...
Rochester in the News
WHEC-TV (July 21)
'Unemployed React to Possible Benefit Extensions'
Mark Zupan, dean of the Simon School, says extending unemployment benefits will increase unemployment. "It's basic economics," says Zupan. "Anytime you provide a greater incentive for a particular activity, you get more of it." Read more...
In Higher Education
Inside Higher Ed (July 20)
'Oil Debate Spills Into Academe'
The debate surrounding professors working for BP is not dissimilar from concerns often raised about professors conducting paid drug research for pharmaceutical companies. Read more...
||Send Us Your News
Submit news or feedback